Fate Therapeutics Inc - FATE - stock price prediction, stock price target, analyst ratings from 11 analysts

Fate Therapeutics Inc has a share price target of US$ 6, revenue growth forecast of -15.0%, and profit growth estimate of 5.5% for FY26, based on top 11 analyst calls.